CalciMedica, Inc. financial data

Symbol
CALC on Nasdaq
Industry
Pharmaceutical Preparations
Location
505 Coast Boulevard South, Suite 307, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CalciMedica, Inc. /DE/ (to 3/22/2023), GRAYBUG VISION, INC. (to 3/15/2023), GRAYBUG, Inc. (to 5/13/2016), GRAYBUG LLC (to 10/7/2014)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464 % +63.1%
Debt-to-equity 58.7 %
Return On Equity -113 % -120%
Return On Assets -71 % +54.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.5M shares +137%
Common Stock, Shares, Outstanding 10.8M shares +89.3%
Entity Public Float 11.7M USD -10%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 11.1M shares +96.5%
Weighted Average Number of Shares Outstanding, Diluted 11.1M shares +96.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 13.4M USD -10.5%
General and Administrative Expense 8.92M USD -59.2%
Operating Income (Loss) -22.4M USD +39.4%
Nonoperating Income (Expense) 8.76M USD +8.63%
Income Tax Expense (Benefit) 1K USD 0%
Net Income (Loss) Attributable to Parent -13.6M USD +52.8%
Earnings Per Share, Basic 16.9 USD/shares +39%
Earnings Per Share, Diluted 16.9 USD/shares +39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.15M USD -21.4%
Cash, Cash Equivalents, and Short-term Investments 14.6M USD 0%
Assets, Current 15.7M USD +2.7%
Property, Plant and Equipment, Net 130K USD -30.5%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 16.2M USD +2.32%
Accounts Payable, Current 1.54M USD +8.4%
Employee-related Liabilities, Current 758K USD -6.77%
Accrued Liabilities, Current 200K USD -34.2%
Liabilities, Current 3.78M USD +2.6%
Operating Lease, Liability, Noncurrent 102K USD
Liabilities 7.18M USD +94.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4K USD
Retained Earnings (Accumulated Deficit) -156M USD -9.58%
Stockholders' Equity Attributable to Parent 9.03M USD -25.7%
Liabilities and Equity 16.2M USD +2.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.72M USD +12%
Net Cash Provided by (Used in) Financing Activities 19M USD -19%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -376%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 10.8M shares +89.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.23M USD -94.7%
Deferred Tax Assets, Valuation Allowance 82.6M USD +192%
Deferred Tax Assets, Gross 82.6M USD +192%
Operating Lease, Liability 117K USD -76.2%
Depreciation 64K USD +25%
Payments to Acquire Property, Plant, and Equipment 4K USD -97.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.6M USD -23%
Lessee, Operating Lease, Liability, to be Paid 118K USD -76.8%
Operating Lease, Liability, Current 203K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 205K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -94.1%
Deferred Tax Assets, Operating Loss Carryforwards 58.5M USD +270%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.1M USD +47.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 13K USD 0%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 118K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 12M USD +759%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%